Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nosocomial pneumonia.

G B Toews1

  • 1Department of Internal Medicine, University of Texas Health Science Center, Dallas.

Clinics in Chest Medicine
|September 1, 1987
PubMed
Summary
This summary is machine-generated.

Nosocomial pneumonias, hospital-acquired infections, are challenging. This review discusses their causes, host defenses, and diagnostic approaches for hospitalized patients with fever and infiltrates.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema.

The European respiratory journal·2010
Same author

TLR9 is expressed in idiopathic interstitial pneumonia and its activation promotes in vitro myofibroblast differentiation.

Histochemistry and cell biology·2008
Same author

Sex differences in physiological progression of idiopathic pulmonary fibrosis.

The European respiratory journal·2008
Same author

Idiopathic pulmonary fibrosis fibroblasts migrate and proliferate to CC chemokine ligand 21.

The European respiratory journal·2007
Same author

Focal interstitial CC chemokine receptor 7 (CCR7) expression in idiopathic interstitial pneumonia.

Journal of clinical pathology·2006
Same author

Augmented pulmonary IL-4 and IL-13 receptor subunit expression in idiopathic interstitial pneumonia.

Journal of clinical pathology·2004
Same journal

Pneumonia Reimagined: Host, Microbe, and the Shifting Landscape of Disease.

Clinics in chest medicine·2026
Same journal

Advocacy in Pneumonia.

Clinics in chest medicine·2026
Same journal

Vaccines Against Pneumonia: Current Updates.

Clinics in chest medicine·2026
Same journal

Non-antibiotic Treatments for Pneumonia: Host-Directed Therapies, Next-Steps and Future Directions.

Clinics in chest medicine·2026
Same journal

Customizing Antibiotic Treatment for Pneumonia: Can We Have a Single Unified Algorithm for All Types of Pneumonia?

Clinics in chest medicine·2026
Same journal

The Role of Complex Digital Interventions to Improve Pneumonia Care.

Clinics in chest medicine·2026
See all related articles

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • Critical Care Medicine

Background:

  • Nosocomial pneumonias represent a significant challenge in healthcare settings.
  • Understanding the pathogenesis, including colonization and host defense, is crucial.

Purpose of the Study:

  • To discuss the pathogenesis of nosocomial pneumonias.
  • To present a diagnostic approach for hospitalized patients with fever and infiltrates.
  • To review available antimicrobial agents for treatment.

Main Methods:

  • Literature review on the pathogenesis of nosocomial pneumonias.
  • Clinical approach based on patient setting, host defenses, and radiographic findings.
  • Review of diagnostic procedures and antimicrobial therapies.

Related Experiment Videos

Main Results:

  • Discussion of colonization and pulmonary defense mechanisms in pneumonia.
  • A structured approach to diagnosing pneumonia in hospitalized patients is outlined.
  • Overview of current antimicrobial agents for treating nosocomial pneumonia.

Conclusions:

  • Effective management requires understanding pathogenesis and employing a systematic diagnostic strategy.
  • Appropriate antimicrobial selection is vital for successful treatment outcomes.
  • Further research into host defense and novel therapies is warranted.